Specialty chemicals manufacturer Vinati Organics experienced a 12.2% year-on-year decline in its financial performance for the December quarter. The company’s net profit dropped to Rs 101 crore in Q3 FY26 from Rs 115 crore in the same period last year. Revenue also decreased by 3.5% to Rs 531 crore compared to Rs 550 crore a year earlier, as per its stock exchange filing.
Operating performance faced pressure during the quarter, with EBITDA falling by 5.2% to Rs 157.5 crore. Operating margins slightly eased to 29.7% from 30.2% in the previous year. Despite these numbers, Vinati Organics remains positive about its medium-term growth prospects. The company anticipates a 15% increase in production volumes in FY26, supported by capacity expansion and the launch of a new manufacturing line.
Vinati Saraf Mutreja, the Managing Director, mentioned that revenue growth might be slightly lower at 10 to 12% due to softer product prices. The company is maintaining a conservative margin outlook of around 27% as it expands into new markets and introduces new products. Shares of Vinati Organics Limited closed higher on Friday, rising by 1.80% to settle at Rs 1,523.50 on the National Stock Exchange (NSE).
Vinati Organics Limited, established in 1989 and headquartered in Mumbai, is a global leader in the specialty chemicals and organic intermediates sector. It is known as the world’s largest manufacturer of Isobutyl Benzene (IBB) and 2-Acrylamido-2-Methylpropane Sulfonic Acid (ATBS). The company exports its products to over 35 countries, with a strong emphasis on quality-driven and sustainable chemical manufacturing.
